OrbusNeich Medical Group Holdings Future Growth
Future criteria checks 1/6
OrbusNeich Medical Group Holdings is forecast to grow earnings and revenue by 0.5% and 10.6% per annum respectively. EPS is expected to grow by 1.2% per annum. Return on equity is forecast to be 11.7% in 3 years.
Key information
0.5%
Earnings growth rate
1.2%
EPS growth rate
| Medical Equipment earnings growth | 33.7% |
| Revenue growth rate | 10.6% |
| Future return on equity | 11.7% |
| Analyst coverage | Low |
| Last updated | 17 Mar 2024 |
Recent future growth updates
No updates
Recent updates
OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem
Apr 25
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%
Mar 13Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down
Feb 04A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)
Oct 20Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding
Jun 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 225 | 58 | 45 | 48 | 2 |
| 12/31/2025 | 206 | 54 | 51 | 57 | 3 |
| 12/31/2024 | 177 | 47 | 47 | 52 | 3 |
| 12/31/2023 | 154 | 45 | 17 | 23 | N/A |
| 9/30/2023 | 152 | 40 | 17 | 22 | N/A |
| 6/30/2023 | 149 | 36 | 18 | 22 | N/A |
| 3/31/2023 | 143 | 27 | 19 | 23 | N/A |
| 12/31/2022 | 137 | 18 | 20 | 23 | N/A |
| 9/30/2022 | 132 | 9 | 19 | 22 | N/A |
| 6/30/2022 | 128 | 0 | 18 | 20 | N/A |
| 3/31/2022 | 122 | -2 | 18 | 20 | N/A |
| 12/31/2021 | 116 | -4 | 18 | 20 | N/A |
| 12/31/2020 | 88 | 7 | 9 | 13 | N/A |
| 12/31/2019 | 96 | 7 | -1 | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6929's forecast earnings growth (0.5% per year) is below the savings rate (2.2%).
Earnings vs Market: 6929's earnings (0.5% per year) are forecast to grow slower than the Hong Kong market (11.7% per year).
High Growth Earnings: 6929's earnings are forecast to grow, but not significantly.
Revenue vs Market: 6929's revenue (10.6% per year) is forecast to grow faster than the Hong Kong market (8.2% per year).
High Growth Revenue: 6929's revenue (10.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6929's Return on Equity is forecast to be low in 3 years time (11.7%).